Arkolith/Insider Trading/CMMB/Form 4

Darvish Nissim

DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Mar 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2022Grant(A)7K—$07K
Apr 19, 2021Grant(A)12K—$012K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-001026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML